← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Shineco, Inc. (SISI) 10-Year Financial Performance & Capital Metrics

SISI • • Industrial / General
HealthcareSpecialty & Generic PharmaConsumer HealthcareVitamins & Supplements
AboutShineco, Inc. engages in processing and distributing specialized fabrics, textiles, and other byproducts derived from an indigenous Chinese plant Apocynum Venetum in the People's Republic of China. The company's specialized fabrics, textiles, and other byproducts are specialized textile and health supplement products to incorporate traditional Eastern medicines with various scientific methods. It also grows and cultivates yew trees, fast-growing bamboo willows, and scenic greening trees; and provides logistic services for agricultural products. The company is headquartered in Beijing, the People's Republic of China.Show more
  • Revenue $10M +1680.6%
  • EBITDA -$12M -49.2%
  • Net Income -$22M -68.0%
  • EPS (Diluted) -5064.66 +41.1%
  • Gross Margin 9% -60.7%
  • EBITDA Margin -123.2% +91.6%
  • Operating Margin -174.11% +89.1%
  • Net Margin -229.03% +90.6%
  • ROE -61.14% -60.5%
  • ROIC -21.59% -63.5%
  • Debt/Equity 0.81 +81.1%
  • Interest Coverage -7.49 -46.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Weak Piotroski F-Score: 2/9
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 2 (bottom 2%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Sales declining 20.7% over 5 years
  • ✗Shares diluted 100.0% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-10.96%
5Y-20.68%
3Y48.03%
TTM139%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-568.77%

EPS CAGR

10Y-
5Y-
3Y-
TTM68.99%

ROCE

10Y Avg-5.2%
5Y Avg-21.91%
3Y Avg-22.38%
Latest-31.58%

Peer Comparison

Vitamins & Supplements
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
SISIShineco, Inc.187.33K0.21016.81%-398.53%-149.29%0.81
SXTCChina SXT Pharmaceuticals, Inc.13.57M0.11-0.01-9.73%-189.77%-21.4%0.06

Profit & Loss

Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Sales/Revenue+32.63M35.21M33.59M43.9M31.22M23.68M3.02M2.19M550.48K9.8M
Revenue Growth %0.04%0.08%-0.05%0.31%-0.29%-0.24%-0.87%-0.28%-0.75%16.81%
Cost of Goods Sold+22.28M24.12M22.85M29.11M22.25M17.56M7.26M3.8M424.29K8.92M
COGS % of Revenue0.68%0.69%0.68%0.66%0.71%0.74%2.4%1.74%0.77%0.91%
Gross Profit+10.35M11.08M10.74M14.79M8.97M6.12M-4.24M-1.61M126.19K882.17K
Gross Margin %0.32%0.31%0.32%0.34%0.29%0.26%-1.4%-0.74%0.23%0.09%
Gross Profit Growth %0.08%0.07%-0.03%0.38%-0.39%-0.32%-1.69%0.62%1.08%5.99%
Operating Expenses+3.85M3.74M3.29M5.52M8.86M9.61M17.18M6.2M8.88M17.95M
OpEx % of Revenue0.12%0.11%0.1%0.13%0.28%0.41%5.68%2.84%16.14%1.83%
Selling, General & Admin3.85M3.74M3.29M5.52M8.86M9.61M17.18M20.26M8.75M17.83M
SG&A % of Revenue0.12%0.11%0.1%0.13%0.28%0.41%5.68%9.27%15.89%1.82%
Research & Development00000000135.85K113.43K
R&D % of Revenue--------0.25%0.01%
Other Operating Expenses0000000-14.06M00
Operating Income+6.5M7.34M7.45M9.27M315.42K-3.49M-21.41M-6.2M-8.76M-17.07M
Operating Margin %0.2%0.21%0.22%0.21%0.01%-0.15%-7.09%-2.84%-15.91%-1.74%
Operating Income Growth %-0.09%0.13%0.01%0.25%-0.97%-12.06%-5.14%0.71%-0.41%-0.95%
EBITDA+7.31M8.21M8.02M9.97M1.11M-3.04M-21.16M-6.2M-8.09M-12.08M
EBITDA Margin %0.22%0.23%0.24%0.23%0.04%-0.13%-7%-2.84%-14.7%-1.23%
EBITDA Growth %-0.06%0.12%-0.02%0.24%-0.89%-3.74%-5.97%0.71%-0.31%-0.49%
D&A (Non-Cash Add-back)811.13K871.1K575.2K698.23K791.53K453.34K255.25K101663.16K4.99M
EBIT8.57M7.34M9.87M9.27M1.68M-5.09M-21.44M-6.2M-9.19M-17.07M
Net Interest Income+42.5K135.4K14.17K-58.77K-12K63.57K29.24K-1.26M-1.71M-2.28M
Interest Income42.5K135.4K14.17K0077.52K29.24K000
Interest Expense00058.77K12K13.95K01.26M1.71M2.28M
Other Income/Expense2.06M2.13M2.43M380.47K1.55M-2.7M-26.51K-1.53M-2.15M-16.9M
Pretax Income+8.57M9.47M9.87M9.65M1.67M-6.19M-21.44M-7.73M-10.91M-33.97M
Pretax Margin %0.26%0.27%0.29%0.22%0.05%-0.26%-7.1%-3.53%-19.81%-3.47%
Income Tax+1.12M1.18M1.25M2.12M787.6K1.09M00-194.56K-758.9K
Effective Tax Rate %0.85%0.86%0.86%0.79%0.48%1.07%1.47%3.18%1.23%0.66%
Net Income+7.28M8.14M8.47M7.59M796.19K-6.63M-31.45M-24.6M-13.36M-22.45M
Net Margin %0.22%0.23%0.25%0.17%0.03%-0.28%-10.41%-11.25%-24.28%-2.29%
Net Income Growth %-0.07%0.12%0.04%-0.1%-0.9%-9.33%-3.74%0.22%0.46%-0.68%
Net Income (Continuing)7.44M8.29M8.62M7.53M365.64K-7.28M-21.44M-7.59M-10.71M-33.21M
Discontinued Operations00000767.94K-10.62M-17.04M-3.24M8.86M
Minority Interest848.15K955.37K1.09M1.05M1.1M1.19M672.35K-398.35K4.29M10.58M
EPS (Diluted)+37269.7841655.0444371.6238804.933826.73-26179.59-85743.16-9590.71-8605.78-5064.66
EPS Growth %-0.07%0.12%0.07%-0.13%-0.9%-7.84%-2.28%0.89%0.1%0.41%
EPS (Basic)37269.7841655.0444371.6238804.933826.73-26179.59-85743.16-9590.71-8605.78-5064.66
Diluted Shares Outstanding1951951911962082533677881.55K4.43K
Basic Shares Outstanding1951951911962082533677881.55K4.43K
Dividend Payout Ratio----------

Balance Sheet

Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Total Current Assets+28.26M35.53M44.73M56.16M60.96M59.52M49.28M59.74M40.92M20.9M
Cash & Short-Term Investments6.14M22.11M23.31M31.49M35.33M32.37M16.34M938.01K625.97K366.14K
Cash Only6.06M22.01M23.15M31.49M35.33M32.37M16.34M938.01K625.97K366.14K
Short-Term Investments87.45K100.27K158.89K0000000
Accounts Receivable11.7M8.25M15.02M15.87M9.87M11.01M2.82M1.82M34.59K1.22M
Days Sales Outstanding130.9385.5163.15131.93115.41169.65340.52304.0822.9345.25
Inventory8.3M4.61M2.35M2.36M2.22M1.8M1.32M0324.41K1.59M
Days Inventory Outstanding135.9969.7337.4829.6536.3537.466.55-279.0765
Other Current Assets1.91M100.27K2.35M1.47M1.71M3.15M21M56.95M37.9M7.67M
Total Non-Current Assets+23.88M21.52M23.56M26.94M22.78M19.57M12.04M4.09M22.55M63.28M
Property, Plant & Equipment5.81M11.04M10.32M11.7M10.67M12.72M5.84M1.65K1.35M6.43M
Fixed Asset Turnover5.62x3.19x3.25x3.75x2.93x1.86x0.52x1323.52x0.41x1.53x
Goodwill000000006.57M13.19M
Intangible Assets1.62M1.41M1.35M2.46M2.34M2.24M1.14M012.05M43.66M
Long-Term Investments11.42M4.77M5.7M6.57M6.65M4.52M8.54M617.45K3.78M0
Other Non-Current Assets4.81M3.98M5.96M6.21M2.96M96.28K5.06M3.47M2.58M0
Total Assets+52.13M57.05M68.28M83.1M83.74M79.09M61.32M63.83M63.47M84.18M
Asset Turnover0.63x0.62x0.49x0.53x0.37x0.30x0.05x0.03x0.01x0.12x
Asset Growth %0.23%0.09%0.2%0.22%0.01%-0.06%-0.22%0.04%-0.01%0.33%
Total Current Liabilities+5.92M6.54M5.03M9.53M10.48M11.35M14.8M29.04M12.01M27.56M
Accounts Payable171.64K259.8K158.07K2.27M220.12K105.24K76.58K191.15K191.15K812.91K
Days Payables Outstanding2.813.932.5228.463.612.193.8518.37164.4433.27
Short-Term Debt3.39M2.75M2.66M2.32M2.41M2.43M2.93M14.42M5.03M19.37M
Deferred Revenue (Current)32.83K9.6K5.44K17.5K382.09K6.32K7.47K6.68K89.49K319.46K
Other Current Liabilities1.35M2.31M655.67K4.93M4.13M7.24M10.14M9.06M-5.23M5.4M
Current Ratio4.77x5.43x8.89x5.89x5.82x5.25x3.33x2.06x3.41x0.76x
Quick Ratio3.37x4.73x8.42x5.65x5.60x5.09x3.24x2.06x3.38x0.70x
Cash Conversion Cycle264.11151.3198.1133.11148.15204.86403.23-137.5776.99
Total Non-Current Liabilities+02.24M594.99K696.84K625.6K1.23M1.15M1.47M14.61M20.04M
Long-Term Debt0000000011.34M10.02M
Capital Lease Obligations00000401.89K352.86K1.03M44.47K0
Deferred Tax Liabilities00011.65K0260.97K285.7K01.42M9.84M
Other Non-Current Liabilities000685.18K625.6K566.02K506.44K1.47M1.81M186.19K
Total Liabilities5.92M6.54M5.03M10.23M11.11M12.58M15.94M30.51M26.62M47.6M
Total Debt+3.39M2.75M2.66M2.32M2.41M2.93M3.72M14.42M16.5M29.66M
Net Debt-2.67M-19.26M-20.49M-29.17M-32.92M-29.44M-12.62M13.48M15.87M29.29M
Debt / Equity0.07x0.05x0.04x0.03x0.03x0.04x0.08x0.43x0.45x0.81x
Debt / EBITDA0.46x0.33x0.33x0.23x2.18x-----
Net Debt / EBITDA-0.37x-2.35x-2.55x-2.93x-29.74x-----
Interest Coverage---157.75x26.29x-250.12x--4.92x-5.12x-7.49x
Total Equity+46.21M50.51M63.25M72.87M72.63M66.51M45.38M33.31M36.85M36.58M
Equity Growth %0.2%0.09%0.25%0.15%-0%-0.08%-0.32%-0.27%0.11%-0.01%
Book Value per Share236558.30258578.70331380.56372679.15349092.16262687.21123734.0042266.6623745.528253.09
Total Shareholders' Equity45.36M49.56M62.17M71.82M71.53M65.33M44.71M33.71M32.56M26M
Common Stock19.32K19.32K21.03K21.23K22.87K3.04K7.88K10.98K26.39K6.74M
Retained Earnings23.02M30.84M39.06M46.05M46.74M40.11M8.66M-18.37M-31.74M-54.34M
Treasury Stock0000000000
Accumulated OCI4.98M1.35M343.47K2.58M14.08K-2.09M3.47M2.1M-794.27K4.13M
Minority Interest848.15K955.37K1.09M1.05M1.1M1.19M672.35K-398.35K4.29M10.58M

Cash Flow

Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Cash from Operations+2.65M13.29M-2.74M9.85M3.5M-4.66M-14.65M-5.71M-5.39M-3.93M
Operating CF Margin %0.08%0.38%-0.08%0.22%0.11%-0.2%-4.85%-2.61%-9.79%-0.4%
Operating CF Growth %-0.72%4.02%-1.21%4.59%-0.64%-2.33%-2.15%0.61%0.06%0.27%
Net Income7.44M8.29M8.62M7.53M881.79K-1.1M-21.44M-24.63M-10.71M-22.45M
Depreciation & Amortization811.13K871.1K575.2K698.23K791.53K1.17M878.35K1.56M663.16K4.99M
Stock-Based Compensation000001.02M001.11M2.87M
Deferred Taxes-64.42K-120.77K86.78K-28.14K-170.48K244.48K0-285.81K-194.56K-771.68K
Other Non-Cash Items-1.21M-1.26M-86.36K1.58M434K313.03K18.38M17.27M4.23M11.21M
Working Capital Changes-4.17M5.66M-10.7M10.39K-2.5M-6.31M-12.47M380.97K-483.02K221.97K
Change in Receivables-3.48M-8.39K-8.14M-3.57M3.77M-2.65M-2.83M-834.89K186.65K10.52M
Change in Inventory-2.81M2.83M2.12M-25.03K68.01K148.54K-4.61M-1.65M474.1K516.97K
Change in Payables133.06K105.38K-96.14K2.15M-1.99M-65.94K-37.67K-75.01K-147.78K1.36M
Cash from Investing+-1.23M3.95M-725.83K-748.96K-246.39K104.78K1.26M-36.02M1.03M-20.98M
Capital Expenditures-101.62K-498.77K-49.86K-1.76M-137.81K-11.05K0-309.46K-18.85K-264.8K
CapEx % of Revenue0%0.01%0%0.04%0%0%0%0.14%0.03%0.03%
Acquisitions----------
Investments----------
Other Investing-1.13M3.98M588.27K777.92K-108.58K36.6K1.26M-22.4M11.43M-7.81M
Cash from Financing+1.53M-255.92K5.38M-485.48K1.81M2.63M7.24M28.41M4.48M11M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing836.65K122.42K5.38M-67.56K1.63M1.13M-970.49K1.73M-74.97K1.55M
Net Change in Cash----------
Free Cash Flow+2.55M12.79M-2.79M8.08M3.36M-4.67M-14.65M-6.02M-5.41M-4.2M
FCF Margin %0.08%0.36%-0.08%0.18%0.11%-0.2%-4.85%-2.75%-9.83%-0.43%
FCF Growth %-0.7%4.03%-1.22%3.89%-0.58%-2.39%-2.14%0.59%0.1%0.22%
FCF per Share13029.4365483.74-14637.4741339.6716151.90-18432.29-39945.35-7640.60-3485.46-946.54
FCF Conversion (FCF/Net Income)0.36x1.63x-0.32x1.30x4.39x0.70x0.47x0.23x0.40x0.18x
Interest Paid223.93K366.84K150.18K133.93K115.38K116.44K115.81K000
Taxes Paid913.29K991.6K845.79K857.2K-694.08K670.77K668.48K000

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)17.2%16.83%14.89%11.15%1.09%-9.53%-56.21%-62.52%-38.09%-61.14%
Return on Invested Capital (ROIC)11.96%14.72%15.09%16.08%0.57%-6.82%-46%-11.69%-13.2%-21.59%
Gross Margin31.71%31.48%31.97%33.69%28.74%25.84%-140.19%-73.67%22.92%9%
Net Margin22.31%23.11%25.21%17.29%2.55%-27.99%-1040.65%-1125.09%-2427.61%-229.03%
Debt / Equity0.07x0.05x0.04x0.03x0.03x0.04x0.08x0.43x0.45x0.81x
Interest Coverage---157.75x26.29x-250.12x--4.92x-5.12x-7.49x
FCF Conversion0.36x1.63x-0.32x1.30x4.39x0.70x0.47x0.23x0.40x0.18x
Revenue Growth4.28%7.9%-4.59%30.68%-28.88%-24.14%-87.24%-27.64%-74.82%1680.61%

Revenue by Segment

201620172018202220232024
Other Agricultural Products--18.83M3.36M2.02M9.24M
Other Agricultural Products Growth----82.13%-39.90%356.71%
Luobuma Products---98.21K43.43K4.44K
Luobuma Products Growth-----55.78%-89.78%
Herbal Products14.03M13.25M14.18M---
Herbal Products Growth--5.61%7.05%---
Luobumaproducts--10.88M---
Luobumaproducts Growth------
Agricultural Products16.79M16.72M----
Agricultural Products Growth--0.39%----
Bluish Dogbane4.39M3.62M----
Bluish Dogbane Growth--17.37%----

Frequently Asked Questions

Growth & Financials

Shineco, Inc. (SISI) reported $9.8M in revenue for fiscal year 2024. This represents a 211% increase from $3.1M in 2005.

Shineco, Inc. (SISI) grew revenue by 1680.6% over the past year. This is strong growth.

Shineco, Inc. (SISI) reported a net loss of $38.9M for fiscal year 2024.

Dividend & Returns

Shineco, Inc. (SISI) has a return on equity (ROE) of -61.1%. Negative ROE indicates the company is unprofitable.

Shineco, Inc. (SISI) generated $1.9M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.